Brookfield Corp’s Pfizer PFE Stock Holding History

Brookfield Corp’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,933	Closed	-$438K	–	414
2023 Q2	$438K	Sell	11,933 -362,587	-97%	-$14.1M	﹤0.01%	512
2023 Q1	$15.3M	Buy	+374,520	New	+$16.2M	0.06%	125
2022 Q2	–	Sell	-169,635	Closed	-$8.78M	–	715
2022 Q1	$8.78M	Sell	169,635 -114,878	-40%	-$5.96M	0.03%	172
2021 Q4	$16.8M	Buy	+284,513	New	+$14.1M	0.06%	93
2021 Q3	–	Sell	-65,055	Closed	-$2.55M	–	595
2021 Q2	$2.55M	Buy	+65,055	New	+$2.53M	0.01%	317
2018 Q3	–	Sell	-200,392	Closed	-$6.9M	–	188
2018 Q2	$6.9M	Hold	200,392	–	–	0.02%	118
2018 Q1	$6.75M	Hold	200,392	–	–	0.03%	119
2017 Q4	$6.89M	Hold	200,392	–	–	0.03%	99
2017 Q3	$6.79M	Hold	200,392	–	–	0.03%	95
2017 Q2	$6.39M	Sell	200,392 -61,416	-23%	-$1.94M	0.03%	97
2017 Q1	$8.5M	Hold	261,808	–	–	0.05%	84
2016 Q4	$8.07M	Hold	261,808	–	–	0.05%	94
2016 Q3	$8.41M	Sell	261,808 -61,059	-19%	-$2.04M	0.05%	91
2016 Q2	$10.8M	Hold	322,867	–	–	0.05%	88
2016 Q1	$9.08M	Buy	322,867 +122,475	+61%	+$3.5M	0.05%	85
2015 Q4	$6.14M	Sell	200,392 -200,392	-50%	-$6.3M	0.03%	109
2015 Q3	$11.9M	Hold	400,784	–	–	0.03%	98
2015 Q2	$12.8M	Buy	+400,784	New	+$13.1M	0.04%	100

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Brookfield Corp's PFE Position: Q3 2023 in Review

Brookfield Corp sold out of Pfizer (PFE) in Q3 2023, closing a stake of 11,933 shares — an estimated $438K sold.

Brookfield Corp first reported a position in PFE in Q2 2015 and held it in 18 quarters. The position peaked at $16.8M in Q4 2021. 2,928 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Brookfield Corp reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Brookfield Corp sold 11,933 Pfizer shares in Q3 2023, an estimated $438K.
Brookfield Corp first reported a position in Pfizer in Q2 2015 and held it in 18 quarters.
Brookfield Corp's Pfizer position peaked at $16.8M in Q4 2021.
2,928 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.